1. Home
  2. AAPG vs SOC Comparison

AAPG vs SOC Comparison

Compare AAPG & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • SOC
  • Stock Information
  • Founded
  • AAPG 2009
  • SOC 2020
  • Country
  • AAPG China
  • SOC United States
  • Employees
  • AAPG N/A
  • SOC N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • SOC
  • Sector
  • AAPG Health Care
  • SOC
  • Exchange
  • AAPG Nasdaq
  • SOC Nasdaq
  • Market Cap
  • AAPG 3.6B
  • SOC 3.0B
  • IPO Year
  • AAPG 2025
  • SOC N/A
  • Fundamental
  • Price
  • AAPG $47.90
  • SOC $28.80
  • Analyst Decision
  • AAPG Buy
  • SOC Buy
  • Analyst Count
  • AAPG 1
  • SOC 4
  • Target Price
  • AAPG N/A
  • SOC $30.50
  • AVG Volume (30 Days)
  • AAPG 8.1K
  • SOC 1.8M
  • Earning Date
  • AAPG 08-20-2025
  • SOC 08-12-2025
  • Dividend Yield
  • AAPG N/A
  • SOC N/A
  • EPS Growth
  • AAPG N/A
  • SOC N/A
  • EPS
  • AAPG N/A
  • SOC N/A
  • Revenue
  • AAPG $54,524,554.00
  • SOC N/A
  • Revenue This Year
  • AAPG N/A
  • SOC N/A
  • Revenue Next Year
  • AAPG $404.41
  • SOC $146.90
  • P/E Ratio
  • AAPG N/A
  • SOC N/A
  • Revenue Growth
  • AAPG N/A
  • SOC N/A
  • 52 Week Low
  • AAPG $16.50
  • SOC $14.90
  • 52 Week High
  • AAPG $48.45
  • SOC $35.00
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • SOC 53.38
  • Support Level
  • AAPG N/A
  • SOC $26.31
  • Resistance Level
  • AAPG N/A
  • SOC $29.81
  • Average True Range (ATR)
  • AAPG 0.00
  • SOC 1.58
  • MACD
  • AAPG 0.00
  • SOC -0.35
  • Stochastic Oscillator
  • AAPG 0.00
  • SOC 45.76

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About SOC Sable Offshore Corp. Common Stock

Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.

Share on Social Networks: